- Home
- LSAK vs ENGN Comparison
LSAK vs ENGN Comparison
Compare LSAK & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSAK
- ENGN
- Stock Information
- Founded
- LSAK 1997
- ENGN 1999
- Country
- LSAK South Africa
- ENGN Canada
- Employees
- LSAK N/A
- ENGN N/A
- Industry
- LSAK Investment Bankers/Brokers/Service
- ENGN
- Sector
- LSAK Finance
- ENGN
- Exchange
- LSAK Nasdaq
- ENGN Nasdaq
- Market Cap
- LSAK 384.3M
- ENGN 349.1M
- IPO Year
- LSAK N/A
- ENGN N/A
- Fundamental
- Price
- LSAK $4.29
- ENGN $7.06
- Analyst Decision
- LSAK
- ENGN Buy
- Analyst Count
- LSAK 0
- ENGN 7
- Target Price
- LSAK N/A
- ENGN $20.29
- AVG Volume (30 Days)
- LSAK 70.6K
- ENGN 262.1K
- Earning Date
- LSAK 11-05-2025
- ENGN 09-11-2025
- Dividend Yield
- LSAK N/A
- ENGN N/A
- EPS Growth
- LSAK N/A
- ENGN N/A
- EPS
- LSAK N/A
- ENGN N/A
- Revenue
- LSAK $659,702,000.00
- ENGN N/A
- Revenue This Year
- LSAK N/A
- ENGN N/A
- Revenue Next Year
- LSAK N/A
- ENGN N/A
- P/E Ratio
- LSAK N/A
- ENGN N/A
- Revenue Growth
- LSAK 16.92
- ENGN N/A
- 52 Week Low
- LSAK $3.39
- ENGN $2.65
- 52 Week High
- LSAK $5.60
- ENGN $11.00
- Technical
- Relative Strength Index (RSI)
- LSAK 46.75
- ENGN 59.88
- Support Level
- LSAK $4.00
- ENGN $6.07
- Resistance Level
- LSAK $4.29
- ENGN $8.35
- Average True Range (ATR)
- LSAK 0.18
- ENGN 0.64
- MACD
- LSAK 0.02
- ENGN -0.00
- Stochastic Oscillator
- LSAK 53.23
- ENGN 45.18
About LSAK Lesaka Technologies Inc.
Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates two reportable segments: Merchant and Consumer. The company operates mainly within South Africa. The Merchant segment that derives majority revenue includes activities related to the provision of goods and services provided to corporate and other juristic entities. It earns fees from processing activities performed for its customers and revenue generated from the distribution of prepaid airtime. The Consumer segment includes activities related to the provision of financial services to customers, including bank accounts, loans, and insurance products. The firm charges monthly administration fees for all bank accounts.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.